129 related articles for article (PubMed ID: 21295027)
1. Beta-lactam antibiotic offers neuroprotection in a spinal muscular atrophy model by multiple mechanisms.
Nizzardo M; Nardini M; Ronchi D; Salani S; Donadoni C; Fortunato F; Colciago G; Falcone M; Simone C; Riboldi G; Govoni A; Bresolin N; Comi GP; Corti S
Exp Neurol; 2011 Jun; 229(2):214-25. PubMed ID: 21295027
[TBL] [Abstract][Full Text] [Related]
2. Establishing a standardized therapeutic testing protocol for spinal muscular atrophy.
Tsai LK; Tsai MS; Lin TB; Hwu WL; Li H
Neurobiol Dis; 2006 Nov; 24(2):286-95. PubMed ID: 16952456
[TBL] [Abstract][Full Text] [Related]
3. Chronic treatment with lithium does not improve neuromuscular phenotype in a mouse model of severe spinal muscular atrophy.
Dachs E; Piedrafita L; Hereu M; Esquerda JE; Calderó J
Neuroscience; 2013 Oct; 250():417-33. PubMed ID: 23876328
[TBL] [Abstract][Full Text] [Related]
4. Transgenic inactivation of murine myostatin does not decrease the severity of disease in a model of Spinal Muscular Atrophy.
Rindt H; Buckley DM; Vale SM; Krogman M; Rose FF; Garcia ML; Lorson CL
Neuromuscul Disord; 2012 Mar; 22(3):277-85. PubMed ID: 22079083
[TBL] [Abstract][Full Text] [Related]
5. Loganin possesses neuroprotective properties, restores SMN protein and activates protein synthesis positive regulator Akt/mTOR in experimental models of spinal muscular atrophy.
Tseng YT; Chen CS; Jong YJ; Chang FR; Lo YC
Pharmacol Res; 2016 Sep; 111():58-75. PubMed ID: 27241020
[TBL] [Abstract][Full Text] [Related]
6. Expression profiling in spinal muscular atrophy reveals an RNA binding protein deficit.
Anderson KN; Baban D; Oliver PL; Potter A; Davies KE
Neuromuscul Disord; 2004 Nov; 14(11):711-22. PubMed ID: 15482955
[TBL] [Abstract][Full Text] [Related]
7. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression.
Rothstein JD; Patel S; Regan MR; Haenggeli C; Huang YH; Bergles DE; Jin L; Dykes Hoberg M; Vidensky S; Chung DS; Toan SV; Bruijn LI; Su ZZ; Gupta P; Fisher PB
Nature; 2005 Jan; 433(7021):73-7. PubMed ID: 15635412
[TBL] [Abstract][Full Text] [Related]
8. Restoring Bcl-x(L) levels benefits a mouse model of spinal muscular atrophy.
Tsai LK; Tsai MS; Ting CH; Wang SH; Li H
Neurobiol Dis; 2008 Sep; 31(3):361-7. PubMed ID: 18590823
[TBL] [Abstract][Full Text] [Related]
9. Smn deficiency causes neuritogenesis and neurogenesis defects in the retinal neurons of a mouse model of spinal muscular atrophy.
Liu H; Beauvais A; Baker AN; Tsilfidis C; Kothary R
Dev Neurobiol; 2011 Feb; 71(2):153-69. PubMed ID: 20862739
[TBL] [Abstract][Full Text] [Related]
10. Abolishing Bax-dependent apoptosis shows beneficial effects on spinal muscular atrophy model mice.
Tsai MS; Chiu YT; Wang SH; Hsieh-Li HM; Lian WC; Li H
Mol Ther; 2006 Jun; 13(6):1149-55. PubMed ID: 16564230
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic strategies for the treatment of spinal muscular atrophy.
Cherry JJ; Androphy EJ
Future Med Chem; 2012 Sep; 4(13):1733-50. PubMed ID: 22924510
[TBL] [Abstract][Full Text] [Related]
12. Neurodevelopmental consequences of Smn depletion in a mouse model of spinal muscular atrophy.
Liu H; Shafey D; Moores JN; Kothary R
J Neurosci Res; 2010 Jan; 88(1):111-22. PubMed ID: 19642194
[TBL] [Abstract][Full Text] [Related]
13. Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice.
Dominguez E; Marais T; Chatauret N; Benkhelifa-Ziyyat S; Duque S; Ravassard P; Carcenac R; Astord S; Pereira de Moura A; Voit T; Barkats M
Hum Mol Genet; 2011 Feb; 20(4):681-93. PubMed ID: 21118896
[TBL] [Abstract][Full Text] [Related]
14. Correlation of survival motor neuron expression in leukocytes and spinal cord in spinal muscular atrophy.
Tsai LK; Yang CC; Ting CH; Su YN; Hwu WL; Li H
J Pediatr; 2009 Feb; 154(2):303-5. PubMed ID: 19150680
[TBL] [Abstract][Full Text] [Related]
15. The protective effects of β-lactam antibiotics in motor neuron disorders.
Hedlund E
Exp Neurol; 2011 Sep; 231(1):14-8. PubMed ID: 21693120
[TBL] [Abstract][Full Text] [Related]
16. A new model to study spinal muscular atrophy: neurite degeneration and cell death is counteracted by BCL-X(L) Overexpression in motoneurons.
Garcera A; Mincheva S; Gou-Fabregas M; Caraballo-Miralles V; Lladó J; Comella JX; Soler RM
Neurobiol Dis; 2011 Jun; 42(3):415-26. PubMed ID: 21333739
[TBL] [Abstract][Full Text] [Related]
17. Riluzole attenuates spinal muscular atrophy disease progression in a mouse model.
Haddad H; Cifuentes-Diaz C; Miroglio A; Roblot N; Joshi V; Melki J
Muscle Nerve; 2003 Oct; 28(4):432-7. PubMed ID: 14506714
[TBL] [Abstract][Full Text] [Related]
18. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy.
Riessland M; Ackermann B; Förster A; Jakubik M; Hauke J; Garbes L; Fritzsche I; Mende Y; Blumcke I; Hahnen E; Wirth B
Hum Mol Genet; 2010 Apr; 19(8):1492-506. PubMed ID: 20097677
[TBL] [Abstract][Full Text] [Related]
19. Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease.
Monani UR
Neuron; 2005 Dec; 48(6):885-96. PubMed ID: 16364894
[TBL] [Abstract][Full Text] [Related]
20. Fishing for a mechanism: using zebrafish to understand spinal muscular atrophy.
Beattie CE; Carrel TL; McWhorter ML
J Child Neurol; 2007 Aug; 22(8):995-1003. PubMed ID: 17761655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
